Chandanreddy Devireddy, MD
Interventional Cardiology · Atlanta, GANPI 1356378301
Payments from drug & device makers
Across 354 payments — averaging $5316.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1.4M
- Abbott$136K
- Recor Medical Inc$76K
- Shockwave Medical, Inc$57K
- Edwards Lifesciences$55K
- W. L. Gore & Associates, Inc.$53K
- plus $56K from 5 others
Across 2 payments — averaging $357.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$715
What the payments were for
- Consulting fees$105,45687%
- Speaking & faculty fees$1,1761%
- Travel & lodging$11,62210%
- Food & beverage$3,1613%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 223 | $1,448,912 |
| Abbott | 35 | $135,825 |
| Recor Medical Inc | 17 | $75,765 |
| Shockwave Medical, Inc | 19 | $57,434 |
| Edwards Lifesciences | 16 | $55,358 |
| W. L. Gore & Associates, Inc. | 36 | $52,781 |
| Procyrion, Inc. | 2 | $39,087 |
| Boston Scientific | 3 | $16,830 |
| Asahi Intecc USA, Inc. | 1 | $48 |
| Cathworks, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$55,200
- SYMPLICITY G3$14,407
- RESOLUTE ONYX$8,325
- Vascular Lithotripsy$5,000
- Resolute$1,176
- PARADISE RENAL DENERVATION SYSTEM$800
- GENERAL - STRUCTURAL HEART$186
- COREVALVE EVOLUT R$162
- Mitra Clip system$147
- CoreValve Evolut$130
How this compares
$1,882,082 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $81,854 |
| XareltoRivaroxaban | 25 | $22,022 |
| BrilintaTicagrelor | 14 | $10,503 |
| Prasugrel Hcl | 15 | $1,745 |
| Metoprolol Succinate | 47 | $749 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 33 | $547 |
| ClopidogrelClopidogrel Bisulfate | 71 | $515 |
| Atorvastatin Calcium | 67 | $500 |
| Carvedilol | 59 | $408 |
| Losartan Potassium | 38 | $311 |
| Nitroglycerin | 16 | $280 |
| Lisinopril | 23 | $230 |
| Amlodipine Besylate | 42 | $213 |
| Pantoprazole Sodium | 28 | $185 |
| Atenolol | 15 | $156 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Atlanta
- David KandzariAtlanta$3.7M
- Pradeep YadavAtlanta$3.5M
- Vasilis BabaliarosAtlanta$2.7M
- William NicholsonAtlanta$2M
- Adam GreenbaumAtlanta$1.8M
- Vivek RajagopalAtlanta$1.3M
- Christopher MeduriAtlanta$1.1M
- Wissam JaberAtlanta$981K
- George HanzelAtlanta$750K
- Andrew KleinAtlanta$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.